Bendit (bendamustine hydrochloride) for Injection

Bendit is a brand-name prescription drug that’s FDA-approved to treat • B-cell non-Hodgkin lymphoma (NHL) that is indolent (slow-growing) and got worse during or within 6 months after treatment with rituximab. • Chronic lymphocytic leukemia (CLL). Brand Name: BENDIT (bendamustine hydrochloride) for Injection, for intravenous infusion Initial U.S. Approval: 2008.

Bendit (bendamustine hydrochloride) for Injection In India and Overseas
Bendit (bendamustine hydrochloride) for Injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Overseas Patient/ Export inquires.

Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Bendit (bendamustine hydrochloride) for Injection

Bendamustine-Hydrochloride is approved to treat: • B-cell non-Hodgkin lymphoma (NHL) that is indolent (slow-growing) and got worse during or within 6 months after treatment with rituximab. • Chronic lymphocytic leukemia (CLL). Bendamustine-Hydrochloride is also being studied in the treatment of other types of cancer.

Bendit for Injection is an alkylating drug indicated for treatment of patients with:
• Chronic lymphocytic leukemia (CLL).
• Indolent B-cell non-Hodgkin’s lymphoma (NHL)

Bendamustine Hydrochloride, A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendamustine hydrochloride damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, Bendeka, and Treanda. Bendamustine hydrochloride is approved to treat: • B-cell non-Hodgkin lymphoma (NHL) that is indolent (slow-growing) and got worse during or within 6 months after treatment with rituximab.
https://www.cancer.gov/about-cancer/treatment/drugs/bendamustinehydrochloride

Drug (Brand / Generic): Bendit / bendamustine hydrochloride
Current Indications: • Chronic lymphocytic leukemia (CLL). • Indolent B-cell non-Hodgkin’s lymphoma (NHL)
Marketed by:: Natco Pharma Ltd
Approval Date: 2008

Available as (Form & Strength): Bendit for Injection single-use vial containing 100 mg of bendamustine HCl as white to off-white lyophilized powder. Bendit (bendamustine hydrochloride) for Injection is supplied in individual cartons of 20 mL amber single-use vials containing 100 mg of bendamustine hydrochloride as a white to off-white lyophilized powder.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.